BackgroundCheck.run
Search For

Wei Sheng Qiu, 385513 Matina Dr, Elk Grove, CA 95757

Known as:
Wei S Qiu Wilson Qiu Weisheng Qiu Wei Shengqi Qui Weisheng Wei O
Related to:
Xie P Chen 74

Wei Qiu Phones & Addresses

Elk Grove, CA   

Sacramento, CA   

Cheyenne, WY   

San Francisco, CA   

Daly City, CA   

Stopover, KY   

805 Mount Vernon Ave, San Francisco, CA 94112    415-7301736   

Work

Position: Building and Grounds Cleaning and Maintenance Occupations

Emails

w***[email protected]
Get Report
Control this profile

Mentions for Wei Sheng Qiu

Career records & work history

License Records

Wei Fung Qiu

Licenses:
License #: 27547 - Active
Issued Date: Jul 10, 2009
Renew Date: Dec 1, 2015
Expiration Date: Nov 30, 2017
Type: Certified Public Accountant

Wei Qiu resumes & CV records

Resumes

Wei Qiu Photo 32

Wei Qiu

Location:
United States
Wei Qiu Photo 33

Wei Qiu

Location:
United States

Publications & IP owners

Us Patents

Conformationally Constrained 3-(4-Hydroxy-Phenyl)-Substituted-Propanoic Acids Useful For Treating Metabolic Disorders

US Patent:
7582803, Sep 1, 2009
Filed:
Sep 8, 2006
Appl. No.:
11/517992
Inventors:
Michelle Akerman - San Francisco CA, US
Sean Brown - San Francisco CA, US
Jonathan B. Houze - San Mateo CA, US
Jinqian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - San Mateo CA, US
Julio C. Medina - San Carlos CA, US
Wei Qiu - Foster City CA, US
Michael J. Schmitt - San Francisco CA, US
Yingcai Wang - Fremont CA, US
Liusheng Zhu - Burlingame CA, US
Rajiv Sharma - Fremont CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07C 43/18
C07C 43/21
A61K 31/075
A61K 31/085
US Classification:
568632, 514557, 514716, 514717
Abstract:
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I:.

Compounds, Pharmaceutical Compositions And Methods For Use In Treating Metabolic Disorders

US Patent:
7649110, Jan 19, 2010
Filed:
Feb 25, 2005
Appl. No.:
11/067377
Inventors:
Michelle Akerman - San Francisco CA, US
Jonathan Houze - San Mateo CA, US
Daniel C. H. Lin - Redwood City CA, US
Jinqian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Jian Luo - Brisbane CA, US
Zhihua Ma - San Mateo CA, US
Julio C. Medina - San Carlos CA, US
Wei Qiu - Foster City CA, US
Jeffrey D. Reagan - Millbree CA, US
Rajiv Sharma - Fremont CA, US
Michael J. Schmitt - San Francisco CA, US
Stephen J. Shuttleworth - Bourne End, GB
Ying Sun - Albany CA, US
Yingcai Wang - Fremont CA, US
Jian Zhang - Foster City CA, US
Liusheng Zhu - Burlingame CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07C 59/40
C07C 65/03
US Classification:
562471, 562426, 562465
Abstract:
The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formulaQ—L—P—L—M—X—L—Awherein the definitions of the variables Q, L, P, L, M, X, Land A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.

Compounds, Pharmaceutical Compositions And Methods For Use In Treating Metabolic Disorders

US Patent:
7816367, Oct 19, 2010
Filed:
Feb 24, 2005
Appl. No.:
10/591214
Inventors:
Michelle Akerman - San Francisco CA, US
Jonathan Houze - San Mateo CA, US
Daniel C. H. Lin - Redwood City CA, US
Jiwen Liu - Foster City CA, US
Jian Luo - Brisbane CA, US
Julio C. Medina - San Carlos CA, US
Wei Qiu - Foster City CA, US
Jeffrey D. Reagan - Millbrae CA, US
Rajiv Sharma - Fremont CA, US
Stephen J. Shuttleworth - Buckinghamshire, GB
Ying Sun - Albany CA, US
Jian Zhang - Foster City CA, US
Liusheng Zhu - Burlingame CA, US
Jinqian Liu - Palo Alto CA, US
Zhihua Ma - San Mateo CA, US
Yingcai Wang - Fremont CA, US
Michael J. Schmitt - San Francisco CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/44
C07D 213/02
US Classification:
514277, 546341
Abstract:
The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formulaQ-L-P-L-M-X-L-Awherein the definitions of the variables Q, L, P, L, M, X, Land A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.

Conformationally Constrained 3-(4-Hydroxy-Phenyl)-Substituted-Propanoic Acids Useful For Treating Metabolic Disorders

US Patent:
2009027, Nov 5, 2009
Filed:
Jul 10, 2009
Appl. No.:
12/460037
Inventors:
Michelle Akerman - San Francisco CA, US
Sean Brown - San Francisco CA, US
Jonathan B. Houze - San Mateo CA, US
Jinqian Liu - Palo Alto CA, US
Jiwen Liu - Foster City CA, US
Zhihua Ma - San Mateo CA, US
Julio C. Medina - San Carlos CA, US
Wei Qiu - Foster City CA, US
Michael J. Schmitt - Oakland CA, US
Rajiv Sharma - Fremont CA, US
Yingcai Wang - Millbrae CA, US
Liusheng Zhu - Foster City CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/505
C07D 263/32
A61K 31/421
A61K 31/415
C07D 231/12
C07D 249/08
A61K 31/4196
C07D 239/26
A61P 3/10
A61K 31/192
C07C 59/72
US Classification:
514256, 548236, 514374, 514406, 5483761, 5482686, 514383, 544335, 514569, 562466
Abstract:
The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I:where the definitions of the variables Q, L,L, M, X, L, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.

Possible Relatives

David Qiu  Dai H Qiu  Dan F Qiu  Doris J Qiu  Eric T Qiu  Fang Qiu  Fei Qiu  Wei Y Kam  Wei E Lam  Wei J Lee 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.